Clinical research on psychedelics gets a boost from new study - McGill University

As psychedelics gain traction as potential treatments for mental health disorders, an international study led by researchers at McGill University, Imperial College London, and the University of Exeter stands to improve the rigour and reliability of clinical research.

Learn more
Previous
Previous

Mark Haden

Next
Next

Ketamine for Mental Health: Insights from the Huberman Lab Podcast